Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Baylor College of Medicine
- SUNY University at Buffalo
- Baylor College of Medicine (BCM)
- Indiana University
- Stanford University
- The Ohio State University
- The University of Arizona
- Umeå University
- University of Liverpool
- University of Minnesota
- University of New England
- University of Oxford
- 2 more »
- « less
-
Field
-
Kapetanovic’s research programmes are the: Discovery and development of new genetic therapies for retinal diseases. Investigation of innovative ocular surgical techniques including robotic eye surgery. Testing
-
/ocular tissue, human PBMCs), Treg cultures, ELiSPOT, and ELISA. Complex murine tissue harvesting, islet cell isolation/transplantation, and blood collection. Systemic, local, and ocular injections, along
-
fellow with expertise in the development, characterization and in vivo evaluation of ocular delivery systems. The person selected for this position will also assist the Principal Investigator, Dr. Abhijit
-
and ocular pain in the context of diabetes, ocular trauma, and other neuropathic diseases. Our research investigates how metabolic dysfunction and tissue injury impair corneal innervation, leading
-
development, medical device research, regenerative medicine approaches, and/or translational biomedical research. Experience in ocular drug delivery, contact lens technologies, advanced therapeutics, or cell
-
degenerative diseases. Focuses heavily on analysis of high-throughput bulk and single-cell multi-omic data (ATAC-seq and RNA-seq) in ocular tissues. Performs other job-related duties as assigned. Minimum
-
heavily on analysis of high-throughput bulk and single-cell multi-omic data (ATAC-seq and RNA-seq) in ocular tissues. Performs other job-related duties as assigned. Minimum Qualifications MD or Ph.D. in
-
interpret studies examining the neural mechanisms of corneal pain and dry eye. Develop and use rodent models of dry eye, ocular surface injury, inflammation, and corneal pain. Perform electrophysiological
-
. The closing date is 3 September 2026. Project description and work tasks Chlamydia trachomatis is a leading cause of urogenital and ocular infections worldwide. Its success as a pathogen hinges on its highly
-
Postdoctoral Associate. The translational research centers on ligandomics—a novel omics technology developed by our group—for drug target discovery and the development of innovative therapies for ocular diseases